Primary Peritoneal Carcinoma Recruiting Phase 0 Trials for Fluorescein (DB00693)

IndicationStatusPhase
DBCOND0028874 (Primary Peritoneal Carcinoma)Recruiting0
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03297489Intravital Microscopy in Evaluating Patients With Primary Peritoneal, Fallopian Tube, or Stage IA-IV Ovarian CancerDiagnostic